Ismael, Musa M.

HRN: 24-46-58  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2024
CLINDAMYCIN 300MG (CAP)
02/03/2024
02/10/2024
PO
300mg
TID
Cellulitis
Waiting Final Action 

Indication:  Empirical De-escalation    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: